Nu-3 Gel for Infected Diabetic Foot Ulcers
Part of Hormones & metabolism, Infections, Skin clinical trials.
This trial tests a new gel (Nu-3) to treat mild infections in diabetic foot ulcers. If you have diabetes and a small, shallow ulcer on or below your ankle with signs of infection, this treatment might help heal it without needing stronger medications.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are at least 18 years old.
- You have a diabetic foot ulcer that is mild, on or below the ankle, and not too deep (it has not reached the tendon or bone).
- The ulcer has signs of mild infection (like redness, warmth, or pain) but you are not taking antibiotics for it now.
- You have good blood flow to your foot, which will be checked by tests like a Doppler ultrasound or blood pressure measurement.
- You have a caregiver who can help apply the study gel and dressings at home.
- You are willing to avoid pregnancy and use birth control if needed, and attend all study visits.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new antibacterial wound dressing to see if it helps heal diabetic foot ulcers safely. It may be an option if your ulcer has been there for over 4 weeks and is not severely infected.
This study tests a new gel treatment (Nu-3) for mild infections in diabetic foot ulcers. The goal is to find the right dose and see if it helps heal these wounds safely.
This study tests whether a new wound gel helps heal diabetic foot ulcers better than the standard gel. It is for people with mild to moderate foot ulcers who have good blood flow and are not taking certain medications.
This Phase 3 trial tests ENERGI-F703 gel to help heal diabetic foot ulcers that have not improved for at least 4 weeks. It may help some people whose wounds meet specific size and non-infection criteria.
This trial tests a new gel (MDI-1228-mesylate) applied to diabetic foot ulcers to see if it helps them heal faster than standard care alone. It is for people who have had a foot ulcer for at least 12 weeks and are already receiving standard treatment.
This trial tests a gel containing a light-activated drug (chlorin E6) for diabetic foot ulcers. The gel is applied to the ulcer and then activated with a special light to help the wound heal. It may be a good option if you have a foot ulcer that hasn't healed in 6 weeks or more.
Hear when a new Diabetic Foot Infection trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.